Lyme Disease R&D Pipeline Analysis Report, H2-2018 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 25, 2018--The “Lyme Disease R&D Pipeline Analysis Report, H2-2018” report has been added to ResearchAndMarkets.com’s offering.
Lyme Disease Drug Development Pipeline Study is the latest publication from this researcher with comprehensive information of Lyme Disease pipeline products.
The Lyme Disease pipeline guide presents complete overview of drugs currently being developed for Lyme Disease. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials.
Drug development phase, current stage, mechanism of action, route of administration, orphan drug / fast track / other designations, drug class are provided for each of the Lyme Disease pipeline candidate. Research and Development progress along with latest news related to each of the Lyme Disease pipeline candidates is included.
Major companies participating in therapeutic development of Lyme Disease are included in this pipeline report. Company wise pre clinical and clinical products along with details of drug originator, co developers/ licensors are provided.
Amid strong interest for cure of Lyme Disease from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Lyme Disease clinical and pre clinical products.
The report assists in identifying potential upcoming companies and drugs in Lyme Disease pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.
Key Topics Covered:
I. Key Findings
1. Companies Investing in Lyme Disease Pipeline
2. Pipeline Candidates
II. Insights into Lyme Disease Pipeline1. Disease Overview2. Phase wise Pipeline Compounds3. Company wise Lyme Disease Pipeline Compounds
4. Lyme Disease Pipeline by Mechanism of Action
III. Lyme Disease Pipeline Compound Details1. Snapshot2. Drug Overview3. Mechanism of Action4. Current Status
5. Clinical Trial Details
IV. Lyme Disease Pipeline Company Briefs
V. Latest News and Developments in Global Lyme Disease Pipeline Market
VI. AppendixFor more information about this report visit https://www.researchandmarkets.com/research/4kxwq7/lyme_disease?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180925005682/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Immune Disorders Drugs,Infectious Diseases Drugs
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/25/2018 09:04 AM/DISC: 09/25/2018 09:04 AM